MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (TELA) ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, ...

Rese-cel myositis BLA submission on track for 2027 based on a 17-patient, single arm registrational cohort design, including an outpatient dosing option No-preconditioning program enrolling in lupus ...

A new lawsuit filed by shareholders of Hasbro against the company and its directors alleges that company leadership has mismanaged Magic: The Gathering by overprinting sets of cards, thereby devaluing ...

PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in ...

Phase 2/3 Duravelo-2 pivotal trial evaluating zelenectide pevedotin (zelenectide) plus pembrolizumab in metastatic urothelial cancer (mUC) successfully identifies 6mg/m 2 zelenectide two weeks on, one ...

SAN FRANCISCO (KRON) — The San Francisco Police Department responded to a barricaded subject incident on the 1400 block of California Street. Police advised people to avoid the area of California and ...

BioMarin Pharmaceutical has stopped giving its experimental drug to new or existing patients in several mid‑stage studies after some participants developed a hip-related injury. The pharmaceutical ...

Stanford University’s Wildfire Resilience Program has released its 2025 annual report, outlining a year of initiatives focused on wildfire preparedness, mitigation, and community safety. The report ...

The federal government holds shocking evidence of UFOs which proves we are not alone — including satellite imagery of out-of-this world craft that look like nothing “we have built,” an expert with ...

AgZen—the startup behind a “feedback optimized” smart spraying system enabling farmers to make 30-50% cuts in chemical inputs without a drop off in yield—has raised a $10 million Series B round led by ...

Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026 Pivotal HOPE-3 Phase 3 trial achieved primary endpoint (PUL v2.0) and key ...

Politico has become a testing ground for how AI clauses in union contracts could shape adoption in newsrooms across the U.S. The PEN Guild represents over 250 workers at Politico and its sister ...